SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-24-034733
Filing Date
2024-04-22
Accepted
2024-04-22 10:10:16
Documents
4
Period of Report
2024-04-22

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea0204371-6k_tiziana.htm 6-K 20482
2 TIZIANA LIFE SCIENCES LTD PRESS RELEASE, DATED APRIL 22, 2024 ea020437101ex99-1_tiziana.htm EX-99.1 15327
3 GRAPHIC ex99-1_001.jpg GRAPHIC 2718
4 GRAPHIC ex99-1_002.jpg GRAPHIC 24909
  Complete submission text file 0001213900-24-034733.txt   75301
Mailing Address 3RD FLOOR, 11-12 ST. JAMES'S SQUARE LONDON, ENGLAND X0 SW1Y 4LB
Business Address 3RD FLOOR, 11-12 ST. JAMES'S SQUARE LONDON, ENGLAND X0 SW1Y 4LB 0044(0) 207-495-2379
Tiziana Life Sciences Ltd (Filer) CIK: 0001723069 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38723 | Film No.: 24859821
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)